Navigation Links
ev3 Inc. to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
Date:5/15/2008

PLYMOUTH, Minn., May 15 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Pat Spangler, senior vice president and chief financial officer, is scheduled to present at the 2008 FBR Capital Markets Spring Investor Conference on Thursday, May 29, 2008 at 2:20 p.m. Eastern Time (1:20 p.m. Central Time and 11:20 a.m. Pacific Time). The 2008 FBR Capital Markets Spring Investor Conference will be held at the Grand Hyatt Hotel, located at 109 East 42nd Street, New York, NY.

To access the webcast, go to the investors' section of the ev3 Web site at http://www.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to improving the lives of patients with vascular disease through the development of innovative endovascular therapies. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH
2. HealthSouth to Present at the 2008 Citigroup Global Healthcare Conference and Jefferies 2nd Annual Healthcare Conference
3. HeartWare to Present at Seventh Annual JMP Securities Research Conference
4. Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference
5. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference
8. EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference
9. Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008
10. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
11. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Newswire/ -- The following is an op-ed by Jeffrey ...ies: ,, Credit Senators John Kerry (D-MA) and R... to the health care debate: a bill ends a glaring ...etonuria (PKU) control their potentially devastati... chronic conditions are treated. "The Medical Foo...
(Date:12/4/2009)...nal of Neurosurgery: Pediatrics finds that operat...oma, or JPA, tumors in the thalamus of the brain c...DTI. The sensitivity of DTI imaging allows for th...n. This information can maximize the potential of...ge to the fiber bundles that are directly related ...
(Date:12/4/2009)...rsonality, study finds , , FRIDAY, Dec. ...ne social network, such as Facebook, reveal the re...new study, which finds that people tend to express.... , "I was surprised by the findings because t... their profiles to promote an enhanced impression ...
(Date:12/4/2009)...ing manufacturer of over-the-counter topical cream...ers’ quality of life, today announced that i...Medical Association (APMA) Seal of Approval for it..., (PRWEB) December 4, 2009...he-counter topical cream and first aid products de...
(Date:12/4/2009)...company GemaTech launches its new approach to emer...t (PRU) is a call re-routing solution offered on a...ganisations to rapidly re-route their incoming cal...tion, with additional voice recording if desired, ...ion . , (PRWEB) December ...
Breaking Medicine News(10 mins):Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Online Identities Likely to Match Reality 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:GemaTech Launches Portable Recovery Unit. The Latest Design in Emergency Telecoms Resilience and Continuity 2
...tarting Down syndrome infants on treadmill trainin...four or five months earlier than with only traditi...sity of Michigan says. , The study also suggests ... from locomotion: social skills, motor skills, adv...
...dyslexia struggle to read because their brains are..., according to a brain-imaging study published thi...euroscience (online October 16). The study found t...ding to the study,s first author, Nadine Gaab, PhD...
...alifornia will simultaneously open their doors We...ited to cover the,festivities, SAN FRANCISCO, Oct... a nursing home. Nurse administrators don,t often,...than 150 nursing homes in California this Hallowee...
...alifornia will simultaneously open their doors We...vited to cover the festivities, LOS ANGELES, Oct....a nursing home. Nurse administrators don,t often,s...han 150 nursing homes in California this Halloween...
...rn, a leading global clinical,research organizatio...al,Trial Management Services, Inc. (CTMS) a Bristo...ces throughout the United States. From February,20...ve experience conducting clinical trials in a wide...
...piest surprise this Halloween may actually be in t...turday at the American Heart Association conferenc...y mini-size Halloween candies when they kept the w...at the American Heart Association conference in Or...
Other Medicine News:Health News:Treadmill training helps Down syndrome babies walk months earlier 2Health News:Sound training rewires dyslexic children's brains for reading 2Health News:Sound training rewires dyslexic children's brains for reading 3Health News:Halloween Events in the Bay Area Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Los Angeles Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Los Angeles Bring Young and Old Together for a Ghoulish Good Time 3Health News:Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc. 2Health News:Food 'tricks' that combat sneaky, creepy Halloween treats 2
(Date:12/3/2009)...ISON, N.J., Dec. 3 A gen...of developing a potentially life-threatening blood...rapies or chemicals is one of several medical disc...est Diagnostics (NYSE: DGX ) will present during...ual Meeting and Exposition, December 5-8, 2009, in...
(Date:12/3/2009)...ILMINGTON, Del., Dec. 3 ParagonRx,...utical risk management and optimal medication use,... the FDA,s draft guidance on REMS - Risk Evaluatio...ons for REMS lifecycle management. Dr. Gary Slatk...t on REMS and risk management programs, will lead ...
(Date:12/3/2009)...N DIEGO, Dec. 3 Cardium ...at its wholly-owned subsidiary, Tissue Repair Comp...ing with the U.S. Food and Drug Administration (FD...TM) product candidate based on positive data from...clinical study. Today,s submission with the FDA c...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 1First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 2Some Birth Control Pills Safer Than Others 54505 1Some Birth Control Pills Safer Than Others 54505 2Some Birth Control Pills Safer Than Others 54505 3Chiropractors Focus on Patients Best Interest 54503 1
...ersome" vaginal atrophy, symptoms among sexually...women; results presented today at 19th Annual Nort...ciety Meeting, ANN ARBOR, Mich., Sept. 24 Additi...pemifene tablets) for the treatment of,symptoms of...n showed that,Ophena(TM) significantly improves a ...
...to Raise Awareness about,the Importance of Clinica...News facts:, -- Most Americans with cancer woul...rials if they knew about them. -- In a surve... unaware or unsure that participation in ...ive percent said they would have been willing to e...
Other Medicine Technology:QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 3QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy 4Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 2Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 3
...VA for CELL-DYN are assayed linearity control kits... patient reportable range of three- and five-part ...linear performance of the analyzer. CVA and CVA fo... for each instrument model and provide instrument-...
LATITUDE® Patient Management System
...tary EX.P.R.T. Release Technology essentially elim... stent shortening,, Unique anatomically des...bifurcation,, 0.014 Rapid Exchange catheter...matic tip,, Radiopaque marker on catheter c...
...s a whole blood hematology control manufactured sp...d the Coulter AcT5diff instruments. The compositio...rential, positioning the populations within the li...oduct offers 105-day closed-vial stability and 14-...
Medicine Products: